Strategies for delivering bone morphogenetic protein for bone healing

Materials Science and Engineering C

Volumn 70, Issue , 2017, Pages 856-869

  Begam, Howa ^a   Nandi, Samit Kumar ^b   Kundu, Biswanath ^c   Chanda, Abhijit ^a  

^a JADAVPUR UNIVERSITY   (India)

^b WEST BENGAL UNIVERSITY OF ANIMAL AND FISHERY SCIENCES   (India)

^c CSIR CENTRAL GLASS AND CERAMIC RESEARCH INSTITUTE   (India)

Author keywords

Bone morphogenetic protein; Calcium phosphate; Platelet rich plasma; Polymer; Scaffold; Transforming Growth Factor Beta

Indexed keywords

CALCIUM PHOSPHATE; COMPOSITE MATERIALS; CONTROLLED DRUG DELIVERY; ENZYME INHIBITION; PLASMA (HUMAN); POLYMERS; SCAFFOLDS; SCAFFOLDS (BIOLOGY); SURGERY; TARGETED DRUG DELIVERY;

BONE MORPHOGENETIC PROTEINS; CERAMIC-POLYMER COMPOSITES; CLINICAL INVESTIGATION; FOOD AND DRUG ADMINISTRATION; LONG BONE FRACTURES; ORAL AND MAXILLOFACIAL SURGERIES; PLATELET RICH PLASMA; TRANSFORMING GROWTH FACTOR BETA;

BONE;

BONE MORPHOGENETIC PROTEIN; DRUG CARRIER;

ANIMAL; BONE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG RELEASE; HUMAN; PATHOLOGY; WOUND HEALING;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; HUMANS; WOUND HEALING;

EID: 84992017403     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2016.09.074     Document Type: Review

References (155)

1. [1] Schindeler, A., McDonald, M.M., Bokko, P., Little, D.G., Bone Remodeling during Fracture Repair: The Cellular Picture. 2008, Elsevier, Seminars in Cell and Developmental Biology, 459–466.
2. [2] Fazzalari, N.L., Bone fracture and bone fracture repair. Osteoporos. Int. 22 (2011), 2003–2006.
3. [3] Deschaseaux, F., Sensebe, L., Heymann, D., Mechanisms of bone repair and regeneration. Trends Mol. Med. 15 (2009), 417–429.
4. [4] Dimitriou, R., Tsiridis, E., Carr, I., Simpson, H., Giannoudis, P.V., The role of inhibitory molecules in fracture healing. Injury 37 (2006), S20–S29.
5. [5] Ai-Aql, Z.S., Alagl, A.S., Graves, D.T., Gerstenfeld, L.C., Einhorn, T.A., Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J. Dent. Res. 87 (2008), 107–118.
6. [6] Bessa, P.C., Casal, M., Reis, R.L., Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J. Tissue Eng. Regen. Med. 2 (2008), 81–96.
7. [7] Urist, M.R., Bone: formation by autoinduction. Science 150 (1965), 893–899.
8. [8] Dimitriou, R., Tsiridis, E., Giannoudis, P.V., Current concepts of molecular aspects of bone healing. Injury 36 (2005), 1392–1404.
9. [9] Vaibhav, B., Nilesh, P., Vikram, S., Anshul, C., Bone morphogenic protein and its application in trauma cases: a current concept update. Injury 38 (2007), 1227–1235.
10. [10] Sakou, T., Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22 (1998), 591–603.
11. [11] Bragdon, B., Moseychuk, O., Saldanha, S., King, D., Julian, J., Nohe, A., Bone morphogenetic proteins: a critical review. Cell. Signal. 23 (2011), 609–620.
12. [12] Wozney, J.M., Rosen, V., Celeste, A.J., Mitsock, L.M., Whitters, M.J., Kriz, R.W., Hewick, R.M., Wang, E.A., Novel regulators of bone formation: molecular clones and activities. Science 242 (1988), 1528–1534.
13. [13] Hua, W., Yankui, L., Anmin, C., Zhiling, Q., Jige, C., Extraction, purification and identification of bone morphogenetic protein in conditioned medium of osteosarcoma cell (MG-63). Chin.-Ger. J. Clin. Oncol. 2 (2003), 234–236.
14. [14] Hanamura, H., Higuchi, Y., Nakagawa, M., Iwata, H., Nogami, H., Urist, M.R., Solubilized bone morphogenetic protein (BMP) from mouse osteosarcoma and rat demineralized bone matrix. Clin. Orthop. Relat. Res. 148 (1980), 281–290.
15. [15] Takaoka, K., Ono, K., Amitani, K., Kishimoto, R., Nakata, Y., Solubilization and concentration of a bone-inducing substance from a murine osteosarcoma. Clin. Orthop. Relat. Res. 148 (1980), 274–280.
16. [16] Mizutani, H., Mera, K., Ueda, M., Iwata, H., A study of the bone morphogenetic protein derived from bovine demineralized dentin matrix. Nagoya J. Med. Sci. 59 (1996), 37–47.
17. [17] Yamashita, H., Ten Dijke, P., Heldin, C.H., Miyazono, K., Bone morphogenetic protein receptors. Bone 19 (1996), 569–574.
18. [18] Chen, F.-M., Zhang, M., Wu, Z.-F., Toward delivery of multiple growth factors in tissue engineering. Biomaterials 31 (2010), 6279–6308.
19. [19] Varkey, M., Gittens, S.A., Uludag, H., Growth factor delivery for bone tissue repair: an update. Expert Opin. Drug Deliv. 1 (2004), 19–36.
20. [20] King, J.A., Storm, E.E., Marker, P.C., Dileone, R.J., Kingsley, D.M., The role of BMPs and GDFs in development of region-specific skeletal structures. Ann. N. Y. Acad. Sci. 785 (1996), 70–79.
21. [21] Gupta, M.C., Khan, S.N., Application of bone morphogenetic proteins in spinal fusion. Cytokine Growth Factor Rev. 16 (2005), 347–355.
22. [22] Kodera, R., Miyazaki, M., Yoshiiwa, T., Kawano, M., Kaku, N., Tsumura, H., Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model. Bone 58 (2014), 26–32.
23. [23] Pelletier, M.H., Oliver, R.A., Christou, C., Yu, Y., Bertollo, N., Irie, H., Walsh, W.R., Lumbar spinal fusion with β-TCP granules and variable Escherichia coli-derived rhBMP-2 dose. Spine J. 14 (2014), 1758–1768.
24. [24] Lowery, G.L., Kulkarni, S., Pennisi, A.E., Use of autologous growth factors in lumbar spinal fusion. Bone 25 (1999), 47S–50S.
25. [25] Jenis, L.G., Banco, R.J., Kwon, B., A prospective study of autologous growth factors (AGF) in lumbar interbody fusion. Spine J. 6 (2006), 14–20.
26. [26] Mannion, R.J., Nowitzke, A.M., Wood, M.J., Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2-but what is the cost?. Spine J. 11 (2011), 527–533.
27. [27] Baas, J., Elmengaard, B., Jensen, T.B., Jakobsen, T., Andersen, N.T., Soballe, K., The effect of pretreating morselized allograft bone with rhBMP-2 and/or pamidronate on the fixation of porous Ti and HA-coated implants. Biomaterials 29 (2008), 2915–2922.
28. [28] Miyazaki, M., Morishita, Y., He, W., Hu, M., Sintuu, C., Hymanson, H.J., Falakassa, J., Tsumura, H., Wang, J.C., A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats. Spine J. 9 (2009), 22–30.
29. [29] Kim, S.-D., Kim, H.-N., Lee, J.-H., Jin, W.J., Hwang, S.J., Kim, H.-H., Ha, H., Lee, Z.H., Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Biochem. Pharmacol. 86 (2013), 782–790.
30. [30] Hoshino, M., Egi, T., Terai, H., Namikawa, T., Takaoka, K., Repair of long intercalated rib defects using porous beta-tricalcium phosphate cylinders containing recombinant human bone morphogenetic protein-2 in dogs. Biomaterials 27 (2006), 4934–4940.
31. [31] Kolambkar, Y.M., Dupont, K.M., Boerckel, J.D., Huebsch, N., Mooney, D.J., Hutmacher, D.W., Guldberg, R.E., An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 32 (2011), 65–74.
32. [32] Tsuzuki, N., Nakao, S., Seo, J.-p., Yamada, K., Haneda, S., Furuoka, H., Tabata, Y., Sasaki, N., Effect of biodegradable gelatin β-tri calcium phosphate sponges containing mesenchymal stem cells and bone morphogenetic protein-2 on equine bone defect. J. Equine Vet. 34 (2014), 903–910.
33. [33] Kim, M.G., Shin, D.M., Lee, S.W., The healing of critical-sized bone defect of rat zygomatic arch with particulate bone graft and bone morphogenetic protein-2. J. Plast. Reconstr. Aesthet. Surg. 63 (2010), 459–466.
34. [34] Liu, X., Rahaman, M.N., Liu, Y., Bal, B.S., Bonewald, L.F., Enhanced bone regeneration in rat calvarial defects implanted with surface-modified and BMP-loaded bioactive glass (13–93) scaffolds. Acta Biomater. 9 (2013), 7506–7517.
35. [35] Henslee, A.M., Spicer, P.P., Yoon, D.M., Nair, M.B., Meretoja, V.V., Witherel, K.E., Jansen, J.A., Mikos, A.G., Kasper, F.K., Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects. Acta Biomater. 7 (2011), 3627–3637.
36. [36] Chen, B., Lin, H., Wang, J., Zhao, Y., Wang, B., Zhao, W., Sun, W., Dai, J., Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials 28 (2007), 1027–1035.
37. [37] Zhou, M., Peng, X., Mao, C., Xu, F., Hu, M., Yu, G.-y., Primate mandibular reconstruction with prefabricated, vascularized tissue-engineered bone flaps and recombinant human bone morphogenetic protein-2 implanted in situ. Biomaterials 31 (2010), 4935–4943.
38. [38] Corinaldesi, G., Piersanti, L., Piattelli, A., Iezzi, G., Pieri, F., Marchetti, C., Augmentation of the floor of the maxillary sinus with recombinant human bone morphogenetic protein-7: a pilot radiological and histological study in humans. Br. J. Oral Maxillofac. Surg. 51 (2013), 247–252.
39. [39] Jiang, X., Gittens, S.A., Chang, Q., Zhang, X., Chen, C., Zhang, Z., The use of tissue-engineered bone with human bone morphogenetic protein-4-modified bone-marrow stromal cells in repairing mandibular defects in rabbits. Int. J. Oral Maxillofac. Surg. 35 (2006), 1133–1139.
40. [40] Haid, R.W., Branch, C.L., Alexander, J.T., Burkus, J.K., Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J. 4 (2004), 527–538.
41. [41] Rihn, J.A., Patel, R., Makda, J., Hong, J., Anderson, D.G., Vaccaro, A.R., Hilibrand, A.S., Albert, T.J., Complications associated with single-level transforaminal lumbar interbody fusion. Spine J. 9 (2009), 623–629.
42. [42] Lewandrowski, K.-U., Nanson, C., Calderon, R., Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases. Spine J. 7 (2007), 609–614.
43. [43] Glassman, S.D., Carreon, L., Djurasovic, M., Campbell, M.J., Puno, R.M., Johnson, J.R., Dimar, J.R., Posterolateral lumbar spine fusion with INFUSE bone graft. Spine J. 7 (2007), 44–49.
44. [44] von Ruden, C., Morgenstern, M., Hierholzer, C., Hackl, S., Gradinger, F.L., Woltmann, A., Buhren, V., Friederichs, J., The missing effect of human recombinant Bone Morphogenetic Proteins BMP-2 and BMP-7 in surgical treatment of aseptic forearm nonunion. Injury 47 (2016), 919–924.
45. [45] Dinopoulos, H., Giannoudis, P.V. IV, The use of bone morphogenetic proteins (BMPs) in long-bone non-unions. Curr. Orthop. 21 (2007), 268–279.
46. [46] Donati, D., Di Bella, C., Lucarelli, E., Dozza, B., Frisoni, T., Aldini, N.N., Giardino, R., OP-1 application in bone allograft integration: preliminary results in sheep experimental surgery. Injury 39 (2008), S65–S72.
47. [47] Azad, V., Breitbart, E., Al-Zube, L., Yeh, S., O'Connor, J.P., Lin, S.S., rhBMP-2 enhances the bone healing response in a diabetic rat segmental defect model. J. Orthop. Trauma 23 (2009), 267–276.
48. [48] Seeherman, H., Wozney, J.M., Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev. 16 (2005), 329–345.
49. [49] Marukawa, E., Asahina, I., Oda, M., Seto, I., Alam, M.I., Enomoto, S., Bone regeneration using recombinant human bone morphogenetic protein-2 (rhBMP-2) in alveolar defects of primate mandibles. Br. J. Oral Maxillofac. Surg. 39 (2001), 452–459.
50. [50] Boyne, P.J., Marx, R.E., Nevins, M., Triplett, G., Lazaro, E., Lilly, L.C., Alder, M., Nummikoski, P., A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int. J. Periodontics Restorative Dent. 17 (1997), 11–25.
51. [51] Triplett, R.G., Nevins, M., Marx, R.E., Spagnoli, D.B., Oates, T.W., Moy, P.K., Boyne, P.J., Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J. Oral Maxillofac. Surg. 67 (2009), 1947–1960.
52. [52] Cochran, D.L., Jones, A.A., Lilly, L.C., Fiorellini, J.P., Howell, H., Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J. Periodontol. 71 (2000), 1241–1257.
53. [53] Reddi, A.H., BMPs: from bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth Factor Rev. 16 (2005), 249–250.
54. [54] Calori, G.M., Donati, D., Di Bella, C., Tagliabue, L., Bone morphogenetic proteins and tissue engineering: future directions. Injury 40 (2009), S67–S76.
55. [55] Lo, K.W.H., Ulery, B.D., Ashe, K.M., Laurencin, C.T., Studies of bone morphogenetic protein-based surgical repair. Adv. Drug Deliv. Rev. 64 (2012), 1277–1291.
56. [56] Sachse, A., Wagner, A., Keller, M., Wagner, O., Wetzel, W.D., Layher, F., Venbrocks, R.A., Hortschansky, P., Pietraszczyk, M., Wiederanders, B., Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. Bone 37 (2005), 699–710.
57. [57] Ueki, K., Takazakura, D., Marukawa, K., Shimada, M., Nakagawa, K., Takatsuka, S., Yamamoto, E., The use of polylactic acid/polyglycolic acid copolymer and gelatin sponge complex containing human recombinant bone morphogenetic protein-2 following condylectomy in rabbits. J. Cranio-Maxillofac. Surg. 31 (2003), 107–114.
58. [58] Alam, S., Ueki, K., Marukawa, K., Ohara, T., Hase, T., Takazakura, D., Nakagawa, K., Expression of bone morphogenetic protein 2 and fibroblast growth factor 2 during bone regeneration using different implant materials as an onlay bone graft in rabbit mandibles. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 103 (2007), 16–26.
59. [59] Kirker-Head, C., Karageorgiou, V., Hofmann, S., Fajardo, R., Betz, O., Merkle, H.P., Hilbe, M., Von Rechenberg, B., McCool, J., Abrahamsen, L., BMP-silk composite matrices heal critically sized femoral defects. Bone 41 (2007), 247–255.
60. [60] Kanczler, J.M., Ginty, P.J., White, L., Clarke, N.M.P., Howdle, S.M., Shakesheff, K.M., Oreffo, R.O.C., The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31 (2010), 1242–1250.
61. [61] Nanno, K., Sugiyasu, K., Daimon, T., Yoshikawa, H., Myoui, A., Synthetic alginate is a carrier of OP-1 for bone induction. Clin. Orthop. Relat. Res. 467 (2009), 3149–3155.
62. [62] Kim, J., Kim, I.S., Cho, T.H., Lee, K.B., Hwang, S.J., Tae, G., Noh, I., Lee, S.H., Park, Y., Sun, K., Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 28 (2007), 1830–1837.
63. [63] Takahashi, Y., Yamamoto, M., Tabata, Y., Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and β-tricalcium phosphate. Biomaterials 26 (2005), 4856–4865.
64. [64] Zhao, J., Shinkai, M., Takezawa, T., Ohba, S., Chung, U.-i., Nagamune, T., Bone regeneration using collagen type I vitrigel with bone morphogenetic protein-2. J. Biosci. Bioeng. 107 (2009), 318–323.
65. [65] Murakami, N., Saito, N., Takahashi, J., Ota, H., Horiuchi, H., Nawata, M., Okada, T., Nozaki, K., Takaoka, K., Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 24 (2003), 2153–2159.
66. [66] Patel, Z.S., Yamamoto, M., Ueda, H., Tabata, Y., Mikos, A.G., Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater. 4 (2008), 1126–1138.
67. [67] Ohyama, T., Kubo, Y., Iwata, H., Taki, W., β-Tricalcium phosphate combined with recombinant human bone morphogenetic protein-2: a substitute for autograft, used for packing interbody fusion cages in the canine lumbar spine. Neurol. Med. Chir. 44 (2004), 234–241.
68. [68] Kaito, T., Myoui, A., Takaoka, K., Saito, N., Nishikawa, M., Tamai, N., Ohgushi, H., Yoshikawa, H., Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite. Biomaterials 26 (2005), 73–79.
69. [69] Lu, H., Kawazoe, N., Kitajima, T., Myoken, Y., Tomita, M., Umezawa, A., Chen, G., Ito, Y., Spatial immobilization of bone morphogenetic protein-4 in a collagen-PLGA hybrid scaffold for enhanced osteoinductivity. Biomaterials 33 (2012), 6140–6146.
70. [70] Zhou, H., Qian, J., Wang, J., Yao, W., Liu, C., Chen, J., Cao, X., Enhanced bioactivity of bone morphogenetic protein-2 with low dose of 2-N, 6-O-sulfated chitosan in vitro and in vivo. Biomaterials 30 (2009), 1715–1724.
71. [71] Zhang, Y., Wu, C., Luo, T., Li, S., Cheng, X., Miron, R.J., Synthesis and inflammatory response of a novel silk fibroin scaffold containing BMP7 adenovirus for bone regeneration. Bone 51 (2012), 704–713.
72. [72] Diab, T., Pritchard, E.M., Uhrig, B.A., Boerckel, J.D., Kaplan, D.L., Guldberg, R.E., A silk hydrogel-based delivery system of bone morphogenetic protein for the treatment of large bone defects. J. Mech. Behav. Biomed. Mater. 11 (2012), 123–131.
73. [73] Liu, X.W., Hu, J., Man, C., Zhang, B., Ma, Y.Q., Zhu, S.S., Insulin-like growth factor-1 suspended in hyaluronan improves cartilage and subchondral cancellous bone repair in osteoarthritis of temporomandibular joint. Int. J. Oral Maxillofac. Surg. 40 (2011), 184–190.
74. [74] Bhakta, G., Lim, Z.X.H., Rai, B., Lin, T., Hui, J.H., Prestwich, G.D., Van Wijnen, A.J., Nurcombe, V., Cool, S.M., The influence of collagen and hyaluronan matrices on the delivery and bioactivity of bone morphogenetic protein-2 and ectopic bone formation. Acta Biomater. 9 (2013), 9098–9106.
75. [75] Cipitria, A., Reichert, J.C., Epari, D.R., Saifzadeh, S., Berner, A., Schell, H., Mehta, M., Schuetz, M.A., Duda, G.N., Hutmacher, D.W., Polycaprolactone scaffold and reduced rhBMP-7 dose for the regeneration of critical-sized defects in sheep tibiae. Biomaterials 34 (2013), 9960–9968.
76. [76] Boden, S.D., Zdeblick, T.A., Sandhu, H.S., Heim, S.E., The use of rhBMP-2 in interbody fusion cages: definitive evidence of osteoinduction in humans: a preliminary report. Spine 25 (2000), 376–381.
77. [77] Autefage, H., Briand-Mésange, F., Cazalbou, S., Drouet, C., Fourmy, D., Gonçalvès, S., Salles, J.-P., Combes, C., Swider, P., Rey, C., Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/β-tricalcium phosphate porous ceramics. J. Biomed. Mater. Res. B Appl. Biomater. 91 (2009), 706–715.
78. [78] Perez, R.A., El-Fiqi, A., Park, J.H., Kim, T.H., Kim, J.H., Kim, H.W., Therapeutic bioactive microcarriers: co-delivery of growth factors and stem cells for bone tissue engineering. Acta Biomater. 10 (2014), 520–530.
79. [79] Akkineni, A.R., Luo, Y., Schumacher, M., Nies, B., Lode, A., Gelinsky, M., 3D plotting of growth factor loaded calcium phosphate cement scaffolds. Acta Biomater. 27 (2015), 264–274.
80. [80] Lee, E.-J., Kim, H.-E., Accelerated bony defect healing by chitosan/silica hybrid membrane with localized bone morphogenetic protein-2 delivery. Mater. Sci. Eng. C 59 (2016), 339–345.
81. [81] Kato, M., Namikawa, T., Terai, H., Hoshino, M., Miyamoto, S., Takaoka, K., Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2. Biomaterials 27 (2006), 3927–3933.
82. [82] Hanseler, P., Jung, U.-W., Jung, R.E., Choi, K.-H., Cho, K.-S., Hammerle, C.H.F., Weber, F.E., Analysis of hydrolyzable polyethylene glycol hydrogels and deproteinized bone mineral as delivery systems for glycosylated and non-glycosylated bone morphogenetic protein-2. Acta Biomater. 8 (2012), 116–123.
83. [83] Kong, X., Wang, J., Cao, L., Yu, Y., Liu, C., Enhanced osteogenesis of bone morphology protein-2 in 2-N, 6-O-sulfated chitosan immobilized PLGA scaffolds. Colloids Surf. B: Biointerfaces 122 (2014), 359–367.
84. [84] Pan, H., Hao, S., Zheng, Q., Li, J., Zheng, J., Hu, Z., Yang, S., Guo, X., Yang, Q., Bone induction by biomimetic PLGA copolymer loaded with a novel synthetic RADA16-P24 peptide in vivo. Mater. Sci. Eng. C 33 (2013), 3336–3345.
85. [85] Zhang, H.-X., Zhang, X.-P., Xiao, G.-Y., Hou, Y., Cheng, L., Si, M., Wang, S.-S., Li, Y.-H., Nie, L., In vitro and in vivo evaluation of calcium phosphate composite scaffolds containing BMP-VEGF loaded PLGA microspheres for the treatment of avascular necrosis of the femoral head. Mater. Sci. Eng. C 60 (2016), 298–307.
86. [86] Rai, B., Teoh, S.-H., Ho, K.H., Hutmacher, D.W., Cao, T., Chen, F., Yacob, K., The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds. Biomaterials 25 (2004), 5499–5506.
87. [87] Subramanian, G., Bialorucki, C., Yildirim-Ayan, E., Nanofibrous yet injectable polycaprolactone-collagen bone tissue scaffold with osteoprogenitor cells and controlled release of bone morphogenetic protein-2. Mater. Sci. Eng. C 51 (2015), 16–27.
88. [88] Kim, S.E., Yun, Y.-P., Han, Y.-K., Lee, D.-W., Ohe, J.-Y., Lee, B.-S., Song, H.-R., Park, K., Choi, B.-J., Osteogenesis induction of periodontal ligament cells onto bone morphogenic protein-2 immobilized PCL fibers. Carbohydr. Polym. 99 (2014), 700–709.
89. [89] Suarez-Gonzalez, D., Barnhart, K., Migneco, F., Flanagan, C., Hollister, S.J., Murphy, W.L., Controllable mineral coatings on PCL scaffolds as carriers for growth factor release. Biomaterials 33 (2012), 713–721.
90. [90] Hart, L.R., Li, S., Sturgess, C., Wildman, R., Jones, J.R., Hayes, W., 3D printing of biocompatible supramolecular polymers and their composites. ACS Appl. Mater. Interfaces 8 (2016), 3115–3122.
91. [91] Rezwan, K., Chen, Q.Z., Blaker, J.J., Boccaccini, A.R., Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27 (2006), 3413–3431.
92. [92] Janeta, M., Rajczakowska, M., Ejfler, J., Lydzba, D., Szafert, S., Synthesis and microstructural properties of the scaffold based on a 3-(trimethoxysilyl) propyl methacrylate-POSS hybrid towards potential tissue engineering applications. RSC Adv. 6 (2016), 66037–66047.
93. [93] Jo, J.Y., Jeong, S.I., Shin, Y.M., Kang, S.S., Kim, S.E., Jeong, C.M., Huh, J.B., Sequential delivery of BMP-2 and BMP-7 for bone regeneration using a heparinized collagen membrane. Int. J. Oral Maxillofac. Surg. 44 (2015), 921–928.
94. [94] Ghaemi, S.R., Delalat, B., Ceto, X., Harding, F.J., Tuke, J., Voelcker, N.H., Synergistic influence of collagen I and BMP 2 drives osteogenic differentiation of mesenchymal stem cells: a cell microarray analysis. Acta Biomater. 34 (2015), 41–52.
95. [95] McLaughlin, S.W., Cui, Z., Starnes, T., Laurencin, C.T., Kan, H.-M., Wu, Q., Nair, L.S., Injectable thermogelling chitosan for the local delivery of bone morphogenetic protein. J. Mater. Sci. Mater. Med. 23 (2012), 2141–2149.
96. [96] Uebersax, L., Merkle, H.P., Meinel, L., Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J. Control. Release 127 (2008), 12–21.
97. [97] Uchida, R., Bhawal, U.K., Kiba, H., Arai, K., Tanimoto, Y., Kuboyama, N., Asakura, T., Nishiyama, N., Effect of plasma-irradiated silk fibroin in bone regeneration. J. Biosci. Bioeng. 118 (2014), 333–340.
98. [98] Quinlan, E., Lopez-Noriega, A., Thompson, E., Kelly, H.M., Cryan, S.A., O'Brien, F.J., Development of collagen-hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering. J. Control. Release 198 (2015), 71–79.
99. [99] Kohara, H., Tabata, Y., Enhancement of ectopic osteoid formation following the dual release of bone morphogenetic protein 2 and Wnt1 inducible signaling pathway protein 1 from gelatin sponges. Biomaterials 32 (2011), 5726–5732.
100. [100] Tsuzuki, N., Otsuka, K., Seo, J., Yamada, K., Haneda, S., Furuoka, H., Tabata, Y., Sasaki, N., In vivo osteoinductivity of gelatin β-tri-calcium phosphate sponge and bone morphogenetic protein-2 on an equine third metacarpal bone defect. Res. Vet. Sci. 93 (2012), 1021–1025.
101. [101] Yamamoto, M., Hokugo, A., Takahashi, Y., Nakano, T., Hiraoka, M., Tabata, Y., Combination of BMP-2-releasing gelatin/β-TCP sponges with autologous bone marrow for bone regeneration of X-ray-irradiated rabbit ulnar defects. Biomaterials 56 (2015), 18–25.
102. [102] Lin, W.-H., Yu, J., Chen, G., Tsai, W.-B., Fabrication of multi-biofunctional gelatin-based electrospun fibrous scaffolds for enhancement of osteogenesis of mesenchymal stem cells. Colloids Surf. B: Biointerfaces 138 (2016), 26–31.
103. [103] Suzuki, K., Anada, T., Miyazaki, T., Miyatake, N., Honda, Y., Kishimoto, K.N., Hosaka, M., Imaizumi, H., Itoi, E., Suzuki, O., Effect of addition of hyaluronic acids on the osteoconductivity and biodegradability of synthetic octacalcium phosphate. Acta Biomater. 10 (2014), 531–543.
104. [104] Kaneko, K., Higuchi, C., Kunugiza, Y., Yoshida, K., Sakai, T., Yoshikawa, H., Nakata, K., Hyaluronan inhibits BMP-induced osteoblast differentiation. FEBS Lett. 589 (2015), 447–454.
105. [105] Bratt-Leal, A.M., Nguyen, A.H., Hammersmith, K.A., Singh, A., McDevitt, T.C., A microparticle approach to morphogen delivery within pluripotent stem cell aggregates. Biomaterials 34 (2013), 7227–7235.
106. [106] Hettiaratchi, M.H., Miller, T., Temenoff, J.S., Guldberg, R.E., McDevitt, T.C., Heparin microparticle effects on presentation and bioactivity of bone morphogenetic protein-2. Biomaterials 35 (2014), 7228–7238.
107. [107] Mercado, A.E., Ma, J., He, X., Jabbari, E., Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly (lactide-co-glycolide fumarate) nanoparticles. J. Control. Release 140 (2009), 148–156.
108. [108] Lee, H.J., Koo, A.N., Lee, S.W., Lee, M.H., Lee, S.C., Catechol-functionalized adhesive polymer nanoparticles for controlled local release of bone morphogenetic protein-2 from titanium surface. J. Control. Release 170 (2013), 198–208.
109. [109] Seo, B.-B., Choi, H., Koh, J.-T., Song, S.-C., Sustained BMP-2 delivery and injectable bone regeneration using thermosensitive polymeric nanoparticle hydrogel bearing dual interactions with BMP-2. J. Control. Release 209 (2015), 67–76.
110. [110] Maire, M., Chaubet, F., Mary, P., Blanchat, C., Meunier, A., Logeart-Avramoglou, D., Bovine BMP osteoinductive potential enhanced by functionalized dextran-derived hydrogels. Biomaterials 26 (2005), 5085–5092.
111. [111] Xiao, W., Fu, H., Rahaman, M.N., Liu, Y., Bal, B.S., Hollow hydroxyapatite microspheres: a novel bioactive and osteoconductive carrier for controlled release of bone morphogenetic protein-2 in bone regeneration. Acta Biomater. 9 (2013), 8374–8383.
112. [112] Liu, R., Wu, X., Li, J., Liu, X., Huang, Z., Yuan, Y., Gao, X., Lin, B., Yu, B., Chen, Y., The promotion of bone tissue regeneration by BMP2-derived peptide P24-loaded calcium phosphate cement microspheres. Ceram. Int. 42 (2016), 3177–3189.
113. [113] Wei, G., Jin, Q., Giannobile, W.V., Ma, P.X., The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28 (2007), 2087–2096.
114. [114] Kim, S.E., Jeon, O., Lee, J.B., Bae, M.S., Chun, H.-J., Moon, S.-H., Kwon, I.K., Enhancement of ectopic bone formation by bone morphogenetic protein-2 delivery using heparin-conjugated PLGA nanoparticles with transplantation of bone marrow-derived mesenchymal stem cells. J. Biomed. Sci. 15 (2008), 771–777.
115. [115] Zhang, S., Doschak, M.R., Uludag, H., Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticles. Biomaterials 30 (2009), 5143–5155.
116. [116] Einhorn, T.A., Clinical applications of recombinant human BMPs: early experience and future development. J. Bone Joint Surg. Am. 85 (2003), 82–88.
117. [117] Friedlaender, G.E., Perry, C.R., Cole, J.D., Cook, S.D., Cierny, G., Muschler, G.F., Zych, G.A., Calhoun, J.H., LaForte, A.J., Yin, S., Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg. Am. 83 (2001), S151–S158.
118. [118] Friess, W., Uludag, H., Foskett, S., Biron, R., Sargeant, C., Characterization of absorbable collagen sponges as rhBMP-2 carriers. Int. J. Pharm. 187 (1999), 91–99.
119. [119] Fischer, J., Kolk, A., Pautke, C., Warnke, P.H., Plank, C., Smeets, R., Future of local bone regeneration-protein versus gene therapy. J. Cranio-Maxillofac. Surg. 39 (2011), 54–64.
120. [120] Geiger, M., Li, R.H., Friess, W., Collagen sponges for bone regeneration with rhBMP-2. Adv. Drug Deliv. Rev. 55 (2003), 1613–1629.
121. [121] Luvizuto, E.R., Tangl, S., Zanoni, G., Okamoto, T., Sonoda, C.K., Gruber, R., Okamoto, R., The effect of BMP-2 on the osteoconductive properties of β-tricalcium phosphate in rat calvaria defects. Biomaterials 32 (2011), 3855–3861.
122. [122] Wang, E.A., Israel, D.I., Kelly, S., Luxenberg, D.P., Bone morphogenetic protein-2 causes commitment and differentiation in C3Hl0T1/2 and 3T3 cells. Growth Factors 9 (1993), 57–71.
123. [123] Luginbuehl, V., Meinel, L., Merkle, H.P., Gander, B., Localized delivery of growth factors for bone repair. Eur. J. Pharm. Biopharm. 58 (2004), 197–208.
124. [124] Jung, M.R., Shim, I.K., Chung, H.J., Lee, H.R., Park, Y.J., Lee, M.C., Yang, Y.I., Do, S.H., Lee, S.J., Local BMP-7 release from a PLGA scaffolding-matrix for the repair of osteochondral defects in rabbits. J. Control. Release 162 (2012), 485–491.
125. [125] van den Dolder, J., de Ruijter, A.J.E., Spauwen, P.H.M., Jansen, J.A., Observations on the effect of BMP-2 on rat bone marrow cells cultured on titanium substrates of different roughness. Biomaterials 24 (2003), 1853–1860.
126. [126] Lei, P., Bian, W.-g., Liang, F.-h., Xu, H.-z., Implanting hydroxyapatite-coated porous titanium with bone morphogenetic protein-2 and hyaluronic acid into distal femoral metaphysis of rabbits. Chin. J. Traumatol. 11 (2008), 179–185.
127. [127] Wilke, A., Traub, F., Kienapfel, H., Griss, P., Cell differentiation under the influence of rh-BMP-2. Biochem. Biophys. Res. Commun. 284 (2001), 1093–1097.
128. [128] Al Mamun, M.A., Khan, M.A.A.M., Alles, N., Matsui, M., Tabata, Y., Ohya, K., Aoki, K., Gelatin hydrogel carrier with the W9-peptide elicits synergistic effects on BMP-2-induced bone regeneration. J. Oral Biosci. 55 (2013), 217–223.
129. [129] Tamai, N., Myoui, A., Hirao, M., Kaito, T., Ochi, T., Tanaka, J., Takaoka, K., Yoshikawa, H., A new biotechnology for articular cartilage repair: subchondral implantation of a composite of interconnected porous hydroxyapatite, synthetic polymer (PLA-PEG), and bone morphogenetic protein-2 (rhBMP-2). Osteoarthr. Cartil. 13 (2005), 405–417.
130. [130] Naudi, K.B., Ayoub, A., McMahon, J., Di Silvio, L., Lappin, D., Hunter, K.D., Barbenel, J., Mandibular reconstruction in the rabbit using beta-tricalcium phosphate (β-TCP) scaffolding and recombinant bone morphogenetic protein 7 (rhBMP-7)-histological, radiographic and mechanical evaluations. J. Cranio-Maxillofac. Surg. 40 (2012), e461–e469.
131. [131] Zhao, B., Katagiri, T., Toyoda, H., Takada, T., Yanai, T., Fukuda, T., Chung, U.-i., Koike, T., Takaoka, K., Kamijo, R., Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J. Biol. Chem. 281 (2006), 23246–23253.
132. [132] Jeon, O., Song, S.J., Kang, S.-W., Putnam, A.J., Kim, B.-S., Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly (L-lactic-co-glycolic acid) scaffold. Biomaterials 28 (2007), 2763–2771.
133. [133] Crouzier, T., Ren, K., Nicolas, C., Roy, C., Picart, C., Layer-by-layer films as a biomimetic reservoir for rhBMP-2 delivery: controlled differentiation of myoblasts to osteoblasts. Small 5 (2009), 598–608.
134. [134] Jha, A.K., Yang, W., Kirn-Safran, C.B., Farach-Carson, M.C., Jia, X., Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release. Biomaterials 30 (2009), 6964–6975.
135. [135] Matsumoto, T., Okazaki, M., Inoue, M., Yamaguchi, S., Kusunose, T., Toyonaga, T., Hamada, Y., Takahashi, J., Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials 25 (2004), 3807–3812.
136. [136] Crouzier, T., Sailhan, F., Becquart, P., Guillot, R., Logeart-Avramoglou, D., Picart, C., The performance of BMP-2 loaded TCP/HAP porous ceramics with a polyelectrolyte multilayer film coating. Biomaterials 32 (2011), 7543–7554.
137. [137] Uludag, H., D'Augusta, D., Palmer, R., Timony, G., Wozney, J., Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J. Biomed. Mater. Res. 46 (1999), 193–202.
138. [138] Strobel, C., Bormann, N., Kadow-Romacker, A., Schmidmaier, G., Wildemann, B., Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants. J. Control. Release 156 (2011), 37–45.
139. [139] Wozney, J.M., Seeherman, H.J., Protein-based tissue engineering in bone and cartilage repair. Curr. Opin. Biotechnol. 15 (2004), 392–398.
140. [140] Lin, Z.-Y., Duan, Z.-X., Guo, X.-D., Li, J.-F., Lu, H.-W., Zheng, Q.-X., Quan, D.-P., Yang, S.-H., Bone induction by biomimetic PLGA-(PEG-ASP) n copolymer loaded with a novel synthetic BMP-2-related peptide in vitro and in vivo. J. Control. Release 144 (2010), 190–195.
141. [141] Lee, S.-Y., Yun, Y.-P., Song, H.-R., Chun, H.J., Yang, D.H., Park, K., Kim, S.E., The effect of titanium with heparin/BMP-2 complex for improving osteoblast activity. Carbohydr. Polym. 98 (2013), 546–554.
142. [142] Kang, Y., Kim, S., Khademhosseini, A., Yang, Y., Creation of bony microenvironment with CaP and cell-derived ECM to enhance human bone-marrow MSC behavior and delivery of BMP-2. Biomaterials 32 (2011), 6119–6130.
143. [143] Dong, X., Wang, Q., Wu, T., Pan, H., Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys. J. 93 (2007), 750–759.
144. [144] Cho, T.-J., Gerstenfeld, L.C., Einhorn, T.A., Differential temporal expression of members of the transforming growth factor β superfamily during murine fracture healing. J. Bone Miner. Res. 17 (2002), 513–520.
145. [145] Takabayashi, Y., Ishihara, M., Sumi, Y., Takikawa, M., Nakamura, S., Kiyosawa, T., Platelet-rich plasma-containing fragmin-protamine micro-nanoparticles promote epithelialization and angiogenesis in split-thickness skin graft donor sites. J. Surg. Res. 193 (2015), 483–491.
146. [146] Chen, W.-H., Lo, W.-C., Hsu, W.-C., Wei, H.-J., Liu, H.-Y., Lee, C.-H., Chen, S.-Y.T., Shieh, Y.-H., Williams, D.F., Deng, W.-P., Synergistic anabolic actions of hyaluronic acid and platelet-rich plasma on cartilage regeneration in osteoarthritis therapy. Biomaterials 35 (2014), 9599–9607.
147. [147] Gu, Y., Wang, G., Zhang, X., Zhang, Y., Zhang, C., Liu, X., Rahaman, M.N., Huang, W., Pan, H., Biodegradable borosilicate bioactive glass scaffolds with a trabecular microstructure for bone repair. Mater. Sci. Eng. C 36 (2014), 294–300.
148. [148] Roldan, J.C., Jepsen, S., Miller, J., Freitag, S., Rueger, D.C., Acil, Y., Terheyden, H., Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7. Bone 34 (2004), 80–90.
149. [149] Schuckert, K.-H., Jopp, S., Osadnik, M., The use of platelet rich plasma, bone morphogenetic protein-2 and different scaffolds in oral and maxillofacial surgery-literature review in comparison with own clinical experience. J. Oral Maxillofacial Res., 2, 2011, e2.
150. [150] Guerreiro, J.P.F., Danieli, M.V., Queiroz, A.O., Deffune, E., Ferreira, R.R., Platelet-rich plasma (PRP) applied during total knee arthroplasty. Rev. Bras. Ortop. 50 (2015), 186–194.
151. [151] Morishita, M., Ishida, K., Matsumoto, T., Kuroda, R., Kurosaka, M., Tsumura, N., Intraoperative platelet-rich plasma does not improve outcomes of total knee arthroplasty. J. Arthroplast. 29 (2014), 2337–2341.
152. [152] Gomes, M.F., Valva, V.N., Vieira, E.M.M., Giannasi, L.C., Salgado, M.A.C., Vilela-Goulart, M.G., Homogenous demineralized dentin matrix and platelet-rich plasma for bone tissue engineering in cranioplasty of diabetic rabbits: biochemical, radiographic, and histological analysis. Int. J. Oral Maxillofac. Surg. 45 (2016), 255–266.
153. [153] Kim, S., Kang, Y., Krueger, C.A., Sen, M., Holcomb, J.B., Chen, D., Wenke, J.C., Yang, Y., Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation. Acta Biomater. 8 (2012), 1768–1777.
154. [154] Valentin-Opran, A., Wozney, J., Csimma, C., Lilly, L., Riedel, G.E., Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin. Orthop. Relat. Res. 395 (2002), 110–120.
155. [155] Matsaba, T., Ramoshebi, L.N., Crooks, J., Ripamonti, U., Transforming growth factor-β supports the rapid morphogenesis of heterotopic endochondral bone initiated by human osteogenic protein-1 via the synergistic upregulation of molecular markers. Growth Factors 19 (2001), 73–86.